| Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma (NCT04874311) | Institut Bergonié | 2022-03-01 |
| A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma (NCT05100628) | Noxopharm Limited | 2022-02-11 |
| Lurbinectedin + Doxorubicin In Leiomyosarcoma (NCT05099666) | Massachusetts General Hospital | 2022-02-04 |
| Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors (NCT05075993) | M.D. Anderson Cancer Center | 2021-11-12 |
| Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients (NCT04757337) | UNICANCER | 2021-06-18 |
| Cabozantinib Combined With PD-1 and CTLA-4 Inhibition in Metastatic Soft Tissue Sarcoma (NCT04551430) | Washington University School of Medicine | 2021-01-05 |
| Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases (NCT03965234) | Roswell Park Cancer Institute | 2020-07-16 |
| Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas (NCT04028063) | University of Colorado, Denver | 2020-01-28 |
| Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma (NCT04200443) | City of Hope Medical Center | 2020-01-14 |
| Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas (NCT03670069) | Fred Hutchinson Cancer Center | 2019-09-30 |
| Phase II Study of Regorafenib as Maintenance Therapy (NCT03793361) | Centre Oscar Lambret | 2019-05-15 |
| Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas (NCT03660930) | University of Washington | 2019-04-01 |
| Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma (NCT03397186) | Fred Hutchinson Cancer Center | 2018-06-19 |
| SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma (NCT03138161) | Sarcoma Oncology Research Center, LLC | 2017-04-13 |
| Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery (NCT03009201) | OHSU Knight Cancer Institute | 2017-03-10 |
| Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS) (NCT03022448) | GWT-TUD GmbH | 2017-02-02 |
| Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery (NCT02500797) | National Cancer Institute (NCI) | 2015-08-13 |
| Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation (NCT01574716) | Morphotek | 2012-08-07 |
| Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma (NCT01514188) | ImmunityBio, Inc. | 2012-01-11 |